Drug Profile
Mupirocin cream
Alternative Names: Bactroban; Bactroban Nasal; CentanyLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antibacterials; Carboxylic acids; Epoxy compounds; Esters; Nonanoic acids; Pyrans; Skin disorder therapies; Small molecules
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Burn infections; Methicillin-resistant Staphylococcus aureus infections; Skin and soft tissue infections; Wound infections
Most Recent Events
- 25 Nov 2011 Launched for Methicillin-resistant Staphylococcus aureus infections in Russia (Intranasal) before November 2011
- 25 Nov 2011 Launched for Skin and soft tissue infections in Russia (Topical) before November 2011
- 23 Nov 2011 Launched for Skin and soft tissue infections in Turkey (Topical) before November 2011